Skip to content
lifestyle.childcarepartnerships.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Immunocore Holdings plc
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
May 31, 2026
Immunocore reports first quarter financial results and provides a business update
May 7, 2026
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
April 19, 2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
April 6, 2026
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
March 17, 2026